金城医药：比索洛尔氨氯地平片等产品取得注册证

Group 1 - The company, Jincheng Pharmaceutical, announced that its wholly-owned subsidiaries, Beijing Jincheng Tail Pharmaceutical Co., Ltd. and Shanghai Jincheng Suzhizhi Pharmaceutical Co., Ltd., received drug registration certificates from the National Medical Products Administration for Bisoprolol Amlodipine Tablets and Cefdinir Dry Suspension [1][1][1] - The products mentioned include "Bisoprolol Amlodipine Tablets" among others [1][1][1] Group 2 - The announcement highlights the company's ongoing efforts to expand its product portfolio and enhance its market presence in the pharmaceutical industry [1][1][1] - The receipt of drug registration certificates is a significant milestone for the company, indicating regulatory approval and potential for commercialization [1][1][1]